Search | IOVS | ARVO Journals

Showing 1 – 20 of 25

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

“Tissue-sparing” approach in Descemet’s Membrane Endothelial Keratoplasty using pupil-dilating eye drops

Tarek Bayyoud; Karl Ulrich Bartz Schimdt; Sebastian Thaler

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3558. doi:

ARVO Annual Meeting Abstract July 2019

Descemet’s Membrane Endothelial Keratoplasty: Long-term development of color and contrast in Fuchs' endothelial corneal dystrophy patients

Tarek Bayyoud; Helmut Wilhelm; Manfred Zierhut; Sebastian Thaler; Karl Ulrich Bartz-Schmidt

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3812. doi:

ARVO Annual Meeting Abstract June 2015

New Method for Isolation of Retinal Ganglion Cells- via Retrograde Transferred Magnetic Beads

Jose Hurst; Jan Halbmann; Johanna Hofmann; Martin Stephan Spitzer; Sebastian Thaler; Sven Schnichels

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3235. doi:

ARVO Annual Meeting Abstract April 2014

3-hydroxykynurenin concentration changes in retina after partial optic nerve crush and NMDA-induced RGC damage in rat

Tomasz Choragiewicz; Sebastian Thaler; Frank Schuettauf; Kamila Wertejuk; Dominika Nowakowska; Michael J Koss; Tomasz Kocki; Anselm G M Junemann; Waldemar A Turski; Robert Rejdak

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):388. doi:

ARVO Annual Meeting Abstract June 2013

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Sebastian Mueller; Rebecca Dollinger; Sebastian Thaler; Johanna Hofmann; Martin Spitzer; Karl Bartz-Schmidt; Peter Szurman; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):413. doi:

ARVO Annual Meeting Abstract April 2011

Effects Of Tempol Treatment In The Rd1 Mouse Model Of Retinal Degeneration

Anna H. Lekawa-Ilczuk; Sebastian Thaler; Sylvia Bolz; Tomasz Choragiewicz; Piotr Stopa; Robert Rejdak; Eberhart Zrenner; Tomasz Zarnowski

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5452. doi:

ARVO Annual Meeting Abstract April 2010

Tempol Protects Against Indocyanine Green Induced Retinal Changes in vivo

M. Fiedorowicz; A. Schatz; G. Willmann; B. Voykov; T. J. Choragiewicz; C. A. May; F. Schuettauf; T. Zarnowski; R. Rejdak; S. Thaler

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3586. doi:

ARVO Annual Meeting Abstract April 2010

Neuroprotective Effect of Ketone Bodies and Ketogenic Diet in Nmda-Induced Rgc Damage in Rat. Possible Involvement of Kynurenic Acid?

T. J. Choragiewicz; S. Thaler; R. Rejdak; M. Fiedorowoicz; W. A. Turski; T. Kocki; M. Tulidowicz-Bielak; E. Zrenner; F. Schuettauf; T. Zarnowski

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3715. doi:

ARVO Annual Meeting Abstract April 2010

Rhodopsin Recovery Dysfunction in Young RCS Rats: Electrophysiological Study

A. D. Baryluk; S. Thaler; R. Rejdak; T. arnowski; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5573. doi:

ARVO Annual Meeting Abstract May 2008

Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model

M. Fiedorowicz; S. Thaler; R. Rejdak; F. Schuettauf; E. Zrenner; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):868. doi:

ARVO Annual Meeting Abstract May 2008

Protective Effect of Tempol From Light- Induced Retinal Degeneration in Brown- Norway Rats

A. D. Baryluk; A. Messias; S. Thaler; R. Rejdak; M. Fiedorowicz; S. Bolz; T. arnowski; F. Gekeler; P. Grieb; E. Zrenner

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1690. doi:

ARVO Annual Meeting Abstract May 2008

DBA/2J Mice as a Model of Cataractogenesis

A. K. Oleszczuk; R. Rejdak; C. Rummelt; M. Kiczynska; T. Zarnowski; F. Scheuttauf; S. Thaler; E. Zrenner; F. Kruse; A. Junemann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2795. doi:

ARVO Annual Meeting Abstract May 2008

Immunohistochemical Identification of L-kynurenine Aminotransferase III in Corpora Amylacea in the Human Retina and Optic Nerve

R. A. Rejdak; C. Rummelt; T. Zarnowski; S. Thaler; E. Okuno; E. Zrenner; F. Kruse; A. Junemann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5203. doi:

ARVO Annual Meeting Abstract May 2008

Neuroprotective Effect of the Ketone Bodies Acetoacetate and β-hydroxybutyrate on Retinal Ganglion Cells in a Rat Model of NMDA Toxicity

T. J. Choragiewicz; S. Thaler; F. Schuettauf; R. Rejdak; E. Zrenner; T. Zarnowski

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5502. doi:

ARVO Annual Meeting Abstract May 2008

In vivo Toxicity Testing of Intravitreal Bevacizumab (Avastin) and Ranibizumab (Lucentis) in Rat Models With and Without Retinal Ganglion Cell Damage

S. Thaler; F. Ziemssen; M. Fiedorowicz; T. Choragiewicz; S. Bolz; E. Zrenner; K.-U. Bartz-Schmidt; F. Schuettauf

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4579. doi:

Retina May 2008

In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina

PDF

Sebastian Thaler; Christos Haritoglou; Tomasz J. Choragiewicz; Andre Messias; Aneta Baryluk; C. Albrecht May; Robert Rejdak; Michal Fiedorowicz; Eberhart Zrenner; Frank Schuettauf
TAGS: electroretinography, eye, retina, toxic effect, dyes, recovery of function, injection site, injections
Invest. Ophthalmol. Vis. Sci.. 2008; 49(5):2120-2126. doi: https://doi.org/10.1167/iovs.07-1476

ARVO Annual Meeting Abstract May 2007

Caspase Inhibitors Are Protective in NMDA-Mediated Retinal Ganglion Cell Death

F. Schuettauf; T. Stein; T. Choragiewicz; R. Rejdak; S. Bolz; D. Zurakowski; M. A. Varde; A. M. Laties; S. Thaler

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):641. doi:

ARVO Annual Meeting Abstract May 2007

Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model

S. Thaler; F. Schuettauf; R. Rejdak; T. J. Choragiewicz; T. Zarnowski; E. Zrenner; Z. Wypych; N. Knap; M. Wozniak; P. Grieb

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3286. doi:

ARVO Annual Meeting Abstract May 2007

Toxicity Study of Rhodamine in the Rat Retina

T. J. Choragiewicz; S. Thaler; F. Schuettauf; A. Messias; A. Baryluk; C. A. May; R. Rejdak; Z. Zagorski; E. Zrenner; C. Haritoglou

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):3682. doi:

Retina August 2006

Administration of Novel Dyes for Intraocular Surgery: An In Vivo Toxicity Animal Study

PDF

Frank Schuettauf; Christos Haritoglou; Christian A. May; Robert Rejdak; Anna Mankowska; Wolfgang Freyer; Kirsten Eibl; Eberhart Zrenner; Anselm Kampik; Sebastian Thaler
TAGS: dyes, toxic effect, ophthalmologic surgical procedures, animal testing, eye
Invest. Ophthalmol. Vis. Sci.. 2006; 47(8):3573-3578. doi: https://doi.org/10.1167/iovs.06-0211

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

“Tissue-sparing” approach in Descemet’s Membrane Endothelial Keratoplasty using pupil-dilating eye drops

Descemet’s Membrane Endothelial Keratoplasty: Long-term development of color and contrast in Fuchs' endothelial corneal dystrophy patients

New Method for Isolation of Retinal Ganglion Cells- via Retrograde Transferred Magnetic Beads

3-hydroxykynurenin concentration changes in retina after partial optic nerve crush and NMDA-induced RGC damage in rat

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Effects Of Tempol Treatment In The Rd1 Mouse Model Of Retinal Degeneration

Tempol Protects Against Indocyanine Green Induced Retinal Changes in vivo

Neuroprotective Effect of Ketone Bodies and Ketogenic Diet in Nmda-Induced Rgc Damage in Rat. Possible Involvement of Kynurenic Acid?

Rhodopsin Recovery Dysfunction in Young RCS Rats: Electrophysiological Study

Age-Dependent Neuroprotection of Retinal Ganglion Cells by Tempol C8-acyl Ester in a Rat NMDA Toxicity Model

Protective Effect of Tempol From Light- Induced Retinal Degeneration in Brown- Norway Rats

DBA/2J Mice as a Model of Cataractogenesis

Immunohistochemical Identification of L-kynurenine Aminotransferase III in Corpora Amylacea in the Human Retina and Optic Nerve

Neuroprotective Effect of the Ketone Bodies Acetoacetate and β-hydroxybutyrate on Retinal Ganglion Cells in a Rat Model of NMDA Toxicity

In vivo Toxicity Testing of Intravitreal Bevacizumab (Avastin) and Ranibizumab (Lucentis) in Rat Models With and Without Retinal Ganglion Cell Damage

In Vivo Toxicity Study of Rhodamine 6G in the Rat Retina

Caspase Inhibitors Are Protective in NMDA-Mediated Retinal Ganglion Cell Death

Neuroprotective Effects of Tempol and Its Acyl Esters in a Rat Partial Optic Nerve Crush Model

Toxicity Study of Rhodamine in the Rat Retina

Administration of Novel Dyes for Intraocular Surgery: An In Vivo Toxicity Animal Study

To View More...

You must be signed into an individual account to use this feature.